News

HICCC oncologists and patients were honored at a benefit for the National Pancreas Foundation this past Thursday, November 21st.
Read More >
Ten members of the Herbert Irving Comprehensive Cancer Center (HICCC) have been named as Highly Cited Researchers, ranking in the top 1% by citations for their field and year of publication, demonstrating significant research influence among their peers.
Read More >
Columbia's cancer center is one of only 14 NCI Community Oncology Research Program (NCORP) sites focused on offering the latest cancer treatments to minority and underserved patients, which make up the population of Washington Heights and adjacent neighborhoods.
Read More >
Researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) have recently completed an important new clinical trial demonstrating benefits of neoadjuvant combination immunotherapy plus chemotherapy in patients with non-small cell lung cancer (NSCLC).
Read More >
New Stomach Cancer Screening Center aids in prevention and improves early diagnosis of stomach cancer.
Read More >
Dr. Lawrence Schwartz reflects on ten years as chair of the department of radiology at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center.
Read More >
A team of researchers at HICCC have uncovered important components of pancreatic cancer cell metabolism, hoping to identify therapeutic options to stop its growth.
Read More >
A team from Columbia University Irving Medical Center and NewYork-Presbyterian Hospital have been awarded a Translational Grant by the V Foundation for Cancer Research for their research into a new signaling pathway as a precision medicine approach to myelodysplasia (MDS) and acute myeloid leukemia (AML).
Read More >

Pages